Single-center analysis of the inappropriate use of human albumin and nutritional support in hospitalized patients with hypoproteinemia in China

Background This study used single-center analysis of human serum albumin clinical usage and enteral-parenteral nutritional support to establish clinical application standards for the rational use of human serum albumin. Methods A total of 1984 patients receiving human serum albumin were enrolled in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2021-03, Vol.49 (3), p.300060520987731-300060520987731
Main Authors: Zhang, Jin, Zhang, ZheTao, Shi, TianLu
Format: Article
Language:English
Subjects:
China
Enteral Nutrition
Humans
Hypoproteinemia
Nutritional Support
Parenteral nutrition
Proteins
Retrospective Clinical Research Report
Retrospective Studies
Serum Albumin, Human
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background This study used single-center analysis of human serum albumin clinical usage and enteral-parenteral nutritional support to establish clinical application standards for the rational use of human serum albumin. Methods A total of 1984 patients receiving human serum albumin were enrolled in this retrospective study to analyze the rational application of human serum albumin and enteral-parenteral nutritional support. Results Among 1984 patients, 1044 (52.6%) were found to have irrational applications for human serum albumin use. Major indications for irrational applications were hypoproteinemia (30.0%) and nutritional support (21.9%). Surgical departments including thoracic surgery, orthopedics, and neurosurgery had the most irrational applications, occupying 18.4%, 8.4%, and 4.2%, respectively. A total of 1627 patients (82%) required nutritional support and 745 (45.8%) had irrational nutritional support. Moreover, 694 patients (35.0%) received human serum albumin as the only source of nutritional support. Conclusions Clinical training and the establishment of an approval system should be used to enhance the rational use of human serum albumin, ensuring medication safety, reducing medical costs, and avoiding the waste of medical resources.
ISSN:0300-0605
1473-2300
DOI:10.1177/0300060520987731